Affordable Invokana® (Canagliflozin) for Type 2 Diabetes - Now Available Worldwide

Summary - Invokana® (canagliflozin) was the first SGLT2 inhibitor approved in the US for type 2 diabetes treatment. However, its price in the US reaches nearly $600 monthly with no generic version locally available. MedsPartner connects patients worldwide with quality-assured generic canagliflozin at $100 for 30 tablets - saving significant money each month. This blog explores the latest updates regarding canagliflozin for type 2 diabetes as of March 2026 and ways to access affordable treatment.

In 2013, the FDA approved Invokana® - the first medicine in an entirely new drug class (SGLT2 inhibitors) to reach the US market. Unlike older diabetes drugs working on insulin or glucose production, Invokana® uses a different approach - it tells your kidneys to flush out excess sugar through urine.

This novel canagliflozin mechanism of action opened possibilities for patients struggling with traditional medicines. Studies showed it effectively lowered blood sugar while promoting modest weight loss - welcome since many diabetes drugs cause weight gain.

The problem? Invokana cost remains prohibitively high at nearly $600 monthly. Insurance helps some, but high deductibles and copays create barriers. MedsPartner helps patients in 45+ countries access affordable canagliflozin through compliant personal importation.

Understanding canagliflozin - mechanism of action

Canagliflozin is a SGLT2 inhibitor - named for the kidney protein it blocks.

Your kidneys normally filter glucose, then reabsorb most back into your bloodstream. The SGLT2 protein handles about 90% of this reabsorption. Canagliflozin blocks this protein - preventing glucose reabsorption. Instead, that sugar leaves through urine - typically 80-120 grams daily.

This offers several advantages. It doesn't depend on insulin or pancreas function. And because you're removing sugar from your bloodstream, you lose calories - about 300-400 daily - explaining the weight loss many experience.

What is Invokana® used for beyond blood sugar control?

Invokana is used for purposes beyond glucose-lowering. The CANVAS trials showed canagliflozin reduced major cardiovascular events - heart attacks, strokes, and cardiovascular death - in patients with established heart disease. The FDA expanded Invokana®'s approval to include cardiovascular risk reduction.

The CREDENCE trial demonstrated Invokana® slowed kidney disease progression in diabetes patients. This led to approval for reducing risk of end-stage kidney disease, cardiovascular death, and hospitalization for heart failure in patients with diabetic kidney disease.

These findings transformed Invokana® from a blood sugar medicine to a treatment addressing multiple diabetes complications simultaneously.

Invokana® vs. other SGLT2 inhibitors

With three main SGLT2 inhibitors available (Invokana®, Jardiance®, Farxiga®) - patients often ask if one is better.

All three work similarly and lower blood sugar comparably. The main differences lie in proven benefits from large studies. Jardiance® has strong cardiovascular death reduction data. Farxiga® shows benefits in heart failure. Invokana® has robust kidney protection data from CREDENCE.

Your doctor chooses based on your specific needs. There's no invokana generic in the US, and the same applies to Jardiance® and Farxiga®. Generic versions exist internationally in countries like India.

Why is Invokana price so high?

Johnson & Johnson developed Invokana® at substantial cost with clinical trials involving over 10,000 patients. Patent protection prevents domestic generic competition. The specialty drug distribution system adds markup layers. 

Patent extensions can prolong exclusivity without generic competition. Meanwhile, international manufacturers in countries with different patent laws already produce quality generic canagliflozin - which MedsPartner offers worldwide through compliant personal imports to patients struggling with costs and co-pays.

Invokana price comparison - branded vs. generic options

Standard dosing is one tablet daily. A typical monthly prescription is 30 tablets.

Branded Invokana® costs $593 monthly. MedsPartner's generic costs $100 monthly.

Monthly savings - $493 (83% reduction) 

Is personal importation of generic canagliflozin legal?

Many countries allow importing prescription medicines for personal use within specific limits. The exact regulations vary, but the principle is similar - with a legitimate medical need and valid prescription, you can import a limited supply for your own treatment.

Rules typically include a prescription accompanied by declaration of personal use, and order sizes limited to 1-3 months of doses.

MedsPartner handles documentation and supports compliance, ensuring your importation meets local requirements.

A patient in Trinidad and Tobago found affordable diabetes control

Carlos, a 58-year-old accountant from Trinidad and Tobago, had been living with type 2 diabetes for over a decade. Initially he was on metformin, but his doctor added canagliflozin later for better glucose control.

While Trinidad and Tobago’s public healthcare system provides free access to essential diabetes medications through programmes like CDAP, availability of newer therapies can be limited in practice, requiring Carlos to purchase the medicine privately. The monthly cost quickly became difficult to sustain.

While researching ways to manage these costs, Carlos came across discussions on Reddit about personal importation of meds. After learning more, he reached out to MedsPartner to explore whether this could be a viable option for him.

With a valid prescription and proper documents, MedsPartner supported him through a compliant personal importation process. This allowed Carlos to access a quality-assured version of canagliflozin at a fraction of his previous cost, making it easier to stay consistent with treatment.

“Before this, I was constantly worried about whether I could afford my meds each month,” Carlos shared. “Now I can focus on managing my diabetes without that stress.”

At MedsPartner we are happy to help patients like Carlos in over 45 countries, including USA, Australia, NZ and UK.

Your questions about canagliflozin and Invokana® answered

Q1. What if I can't afford my Invokana® copay?

A - Start with the manufacturer savings program - Janssen offers savings cards that may reduce copays to $0-$10 monthly for eligible commercially-insured patients (not available for Medicare/Medicaid). Patient assistance programs provide free medicine for qualifying low-income uninsured patients. When these don't work or you're ineligible, many patients access quality-assured generic canagliflozin through compliant personal importation via MedsPartner at 83% savings.

Q2. How do I know MedsPartner's generic canagliflozin is legitimate?

A - MedsPartner sources canagliflozin from FDA/EMA-certified manufacturers in India. The generic has to pass bioequivalence testing for approval - which means it has the same active ingredient and similar effects as the branded med. We provide complete manufacturer details and expiration dates with each order. Our 9-year track record includes 30,000+ successful deliveries with verified reviews and a 4.5-star Trustpilot rating. 

Q3. How to order Invokana® generic from MedsPartner?

A - Visit MedsPartner's canagliflozin product page and upload your prescription - no payment required. Our team verifies your prescription and checks your country's regulations. We provide final pricing including shipping. After confirmation and payment, we handle customs paperwork and ship via international carriers as per your country’s personal import rules.

Q4. Can I as a doctor help patients access Invokana® generic from MedsPartner?

A - Yes. Many doctors recommend MedsPartner when patients face financial barriers to treatment. Write to us at support@medspartner.com - we will connect with your patient directky and help them order generic canagliflozin as per your local regulations.

Q5. What savings can I expect from switching to MedsPartner’s generic canagliflozin?

A - At standard 100mg daily dosing (30 tablets monthly), branded Invokana® costs $593 in the US. MedsPartner's generic canagliflozin costs $100 monthly. You save $493 monthly - that's an 83% cost reduction or $5,916 yearly. 

Q6. What are canagliflozin side effects vs. side effects of Invokana?

A - Both generic canagliflozin and branded Invokana have similar side effects as they contain the same active ingredient. Common ones include yeast infections, urinary tract infections, and increased urination. Some people experience dehydration or dizziness, particularly when standing up quickly. More serious but rare risks include diabetic ketoacidosis, Fournier's gangrene, and bone fractures. Always report unusual symptoms to your doctor for the right support.

Diabetes management shouldn't come at crippling costs

Type 2 diabetes isn't a short-term problem - it's a lifelong condition requiring consistent medicine, monitoring, and lifestyle management. Invokana® offers meaningful benefits beyond blood sugar control, including cardiovascular protection and kidney disease prevention. These benefits only materialize if you can afford to take the medicine every single day.

MedsPartner bridges this gap by offering affordable global access to generic canagliflozin. Reach out to support@medspartner.com or order directly on our website. We're here to help you get the medicines you need at prices you can afford!

Author Bio - Gunjan Agrawal brings deep experience in global healthcare logistics and cross-border medicine access. At MedsPartner - she oversees the intricate process of delivering essential treatments to patients worldwide - ensuring safety, affordability & regulatory compliance at every step. Her work draws on years of hands-on expertise in supplier management, quality assurance & international coordination - experience that has shaped her nuanced understanding of the real-world challenges in making healthcare truly accessible.